Yeshiva University: Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
April 04, 2020
April 04, 2020
BRONX, New York, April 4 [TNSmedicalresearch] -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This . . .
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial. This . . .